Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-001351
Filing Date
2023-01-20
Accepted
2023-01-20 16:21:29
Documents
9
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A arwr_xpre14ax12023.htm PRE 14A 1023946
2 arrowhead_pagex1.jpg GRAPHIC 203705
3 chart-83b849fba1fd46c3aa4.jpg GRAPHIC 21071
4 chart-e29867e0d3a0494fa3a.jpg GRAPHIC 130338
5 g298856g08m78.jpg GRAPHIC 50524
6 g298856g27e04.jpg GRAPHIC 54665
7 g298856g70d20.jpg GRAPHIC 68095
8 proxycard1cc.jpg GRAPHIC 446798
9 proxycard2cc.jpg GRAPHIC 181070
  Complete submission text file 0001628280-23-001351.txt   2617909
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-38042 | Film No.: 23541240
SIC: 2834 Pharmaceutical Preparations